Offline mode

Intended Purpose
Enzyme immunoassay for the quantitative determination of histamine in human EDTA plasma and urine. The Histamine ELISA is useful as an aid for diagnosis of allergic disorders by assessing the patient's health status using the physiological marker histamine. Of clinical interest in the histamine determination is the quantification of the histamine release from basophilic leukocytes in allergies of the "immediate type" as well as of the histamine quantity which is present in various body fluids (plasma, urine), after allergen administration. Patient population includes adults suspected to be affected by allergies. The Histamine ELISA is a solid phase enzyme-linked immunosorbent assay (ELISA), based on the principle of competitive binding and measured on an absorbance reader. The assay is semi-automated requiring general purpose laboratory instruments and consumables such as absorbance microplate reader/washer, vortexer and pipettes to execute the test. Test results may be calculated from a standard curve and compared to laboratory established reference ranges from healthy adults (i.e. normal ranges). The test kit is intended for professional laboratory use only. The test kit is not for self-testing. The Histamine ELISA is NOT intended for near-patient testing.

Clinical significance
Histamine ((2-(imidazol-4-yl)ethylamine); ß-imidazolethylamine) was named after the Greek word for tissue histos and is the most important mediator substance in humans and appears primarily in the initial phase of the anaphylactic reaction (allergy of the immediate type). It is considered to be a major mediator of numerous pathological processes and to regulate several essential processes in allergy and autoimmune diseases.[1-4] Histamine plays a central role in stimulating the development of allergy-related inflammatory diseases by regulating the maturation and activation of leukocytes and controlling their migration to target sites where they cause chronic inflammation. Histamine also exerts a number of other immunoregulatory functions by modulating the functions of various cells.[4-6] The clinical interest of histamine determination lies once in the quantification of histamine release from basophilic leukocytes in allergies of the immediate type, as well as the amount of histamine present in the various body fluids (plasma, urine) after allergen administration has occurred.[7,8]

For concrete data please consult the Instruction for Use in the download box on the top right side.

  1. Maintz, L., Benfadal, S., Allam, J. P., Hagemann, T., Fimmers, R., & Novak, N. (2006). Evidence for a reduced histamine degradation capacity in a subgroup of patients with atopic eczema. Journal of allergy and clinical immunology, 117(5), 1106-1112.
  2. Comas-Basté, O., Sánchez-Pérez, S., Veciana-Nogués, M. T., Latorre-Moratalla, M., & Vidal-Carou, M. D. C. (2020). Histamine intolerance: The current state of the art. Biomolecules, 10(8), 1181
  3. Shahid, M., Tripathi, T., Sobia, F., Moin, S., Siddiqui, M., & Khan, R. A. (2009). Histamine, histamine receptors, and their role in immunomodulation: an updated systematic review. The Open Immunology Journal, 2(1).
  4. Church, M. K. (2016). Allergy, histamine and antihistamines. Histamine and Histamine Receptors in Health and Disease, 321-331.
  5. Thangam, E. B., Jemima, E. A., Singh, H., Baig, M. S., Khan, M., Mathias, C. B., & Saluja, R. (2018). The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the hunt for new therapeutic targets. Frontiers in immunology, 9, 1873.
  6. White, M. V. (1990). The role of histamine in allergic diseases. Journal of allergy and clinical immunology, 86(4), 599-605.
  7. Kawakami, T., Kashiwakura, J. I., & Kawakami, Y. (2014). Histamine-releasing factor and immunoglobulins in asthma and allergy. Allergy, asthma & immunology research, 6(1), 6-12
  8. Moss, J. & Beaven, M. A. (1981). Hormonal and hemodynamic profile of an anaphylactic reaction in man. Circulation, 63(1), 210-213.

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.